Tokumura A et al. |
Contractile effect of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine on strips of isolated rat intestine. |
1984 |
J. Pharm. Pharmacol. |
pmid:6144763
|
Pirotzky E et al. |
Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys. |
1984 |
Kidney Int. |
pmid:6144811
|
Rao AK et al. |
Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects. |
1984 |
Am. J. Hematol. |
pmid:6431801
|
Siess W et al. |
Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. |
1984 |
J. Biol. Chem. |
pmid:6429141
|
Malpass TW et al. |
The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass. |
1984 |
J. Thorac. Cardiovasc. Surg. |
pmid:6231433
|
Dewar A et al. |
Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig. |
1984 |
J. Pathol. |
pmid:6481526
|
Goldstein BM et al. |
Effect of platelet activating factor (PAF) on blood flow distribution in the spontaneously hypertensive rat. |
1984 |
Life Sci. |
pmid:6482659
|
Baldo BA and Tovey ER |
Allergy, allergens and allergen standardization. |
1984 |
Med. J. Aust. |
pmid:6482786
|
Kasuya Y et al. |
Hypotensive actions of some analogues of platelet-activating factor (PAF) with higher potencies than natural PAF. |
1984 |
Can. J. Physiol. Pharmacol. |
pmid:6733593
|
Page CP et al. |
Platelets and bronchospasm. |
1984 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6735490
|
Masugi F et al. |
Effect of 1-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the rat. |
1984 |
Life Sci. |
pmid:6694519
|
Bottecchia D et al. |
Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation. |
1984 |
Scand J Haematol |
pmid:6695148
|
Blank ML et al. |
A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6696762
|
Kasuya Y et al. |
Possible role of endothelium in the vasodilator response of rat thoracic aorta to platelet activating factor (PAF). |
1984 |
J. Pharmacobio-dyn. |
pmid:6726619
|
Beaubien BB et al. |
Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6594998
|
Roubin R et al. |
The role of immunomodulators in the production of lipid mediators by macrophages (M phi). |
1984 |
Int J Tissue React |
pmid:6596298
|
Lefer AM et al. |
Pathophysiological mechanisms of sudden death induced by platelet activating factor. |
1984 |
Br. J. Pharmacol. |
pmid:6435705
|
Gunby P |
A new piece for the puzzle of inflammation. |
1984 |
JAMA |
pmid:6420583
|
Lian EC et al. |
Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma. |
1984 |
Thromb. Res. |
pmid:6420930
|
Billah MM and Siegel MI |
Calmodulin antagonists inhibit formation of platelet-activating factor in stimulated human neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6422930
|